GSK plc - Common Stock

Historical Holders from Q3 2022 to Q3 2025

Type / Class
Equity / Common Stock
Shares outstanding
4,152,540,607
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
3,023,620
Holdings value
$64,091,192
% of all portfolios
0%
Number of holders
2
Number of buys
1
Number of sells
-1
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of GSK plc - Common Stock

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.9% $6,226,766,199 369,576,114 BlackRock, Inc. 31 Dec 2024

Institutional Holders of GSK plc - Common Stock

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 3,023,620 $64,091,192 -$2,720,953 $21.21 2
2025 Q2 3,152,006 $60,038,985 +$1,307,979 $19.05 1
2025 Q1 3,083,338 $58,184,947 -$5,349,963 $18.87 1
2024 Q4 3,366,844 $56,776,996 -$1,496,070 $16.85 2
2024 Q3 3,454,929 $70,278,689 -$1,369,668 $20.34 2
2024 Q2 3,530,417 $68,276,093 -$618,649 $19.33 2
2024 Q1 3,562,405 $76,837,080 +$433,136 $21.58 2
2023 Q4 3,542,376 $65,405,413 +$2,134,511 $18.47 2
2023 Q3 3,426,777 $62,371,831 -$757,680 $18.2 2
2023 Q2 3,468,406 $61,190,492 +$7,286,309 $17.65 2
2023 Q1 3,055,459 $53,866,437 -$358,145 $17.63 1
2022 Q4 3,075,774 $53,427,796 +$5,174,661 $17.37 1
2022 Q3 2,777,875 $44,475,000 +$44,475,000 $16.01 1